MAPK6 and cancer: In addition, the underlying mechanisms of SNHG6 have been extensively elucidated in other different types of cancer via numerous molecular pathways, including targeting of TAK1/JNK and Wnt/β-catenin signalling pathway-relevant genes [35], inhibition of the expression of MAPK6 by upregulating miR-26a-5p [36], and so on.